Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
transporter for fosfomycin uptake
Overview
Fosfomycin |
Reslit |
| Candidate |
| C942A | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| G1073T | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| E350Q | - | hexose phosphate transporter UhpT, single resistance variant | Escherichia coli, Klebsiella pneumoniae | FosfomycinFOSFOMYCIN | Card DatabaseReference Gene CatalogReslit | Confirmed |
| V434I | - | - | Escherichia coli, Klebsiella pneumoniae | Fosfomycin | Reslit | Candidate |
| I149M | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| V85L | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| K132E | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| C109W | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| Y165H | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| S26R | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| G134D | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| H50P | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| V18L | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| W44C | - | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| T1273C | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| N348T | - | - | - | Fosfomycin | Reslit | Candidate |
| Q17Y | - | - | - | Fosfomycin | Reslit | Candidate |
| T352S | - | - | - | Fosfomycin | Reslit | Candidate |
| E444Q | - | - | - | Fosfomycin | Reslit | Candidate |
| K448E | - | - | - | Fosfomycin | Reslit | Candidate |
| E359G | - | - | - | Fosfomycin | Reslit | Candidate |
| Q443E | - | - | - | Fosfomycin | Reslit | Candidate |
| T435A | - | - | - | Fosfomycin | Reslit | Candidate |
| K356S | - | - | - | Fosfomycin | Reslit | Candidate |
| F297L | - | - | - | Fosfomycin | Reslit | Candidate |
| C99G | - | - | - | Fosfomycin | Reslit | Candidate |
| E349A | - | - | - | Fosfomycin | Reslit | Candidate |
| D362E | - | - | - | Fosfomycin | Reslit | Candidate |
| L457V | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| G358V | - | hexose phosphate transporter UhpT, single resistance variant | Staphylococcus aureus | FosfomycinFOSFOMYCIN | Card DatabaseReference Gene CatalogReslit | Confirmed |
| G67A | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| W278R | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| D317Y | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| G140R | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| A305V | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| Q136K | - | - | Staphylococcus aureus | Fosfomycin | Reslit | Candidate |
| G112E | - | hexose phosphate transporter UhpT, single resistance variant | Staphylococcus aureus | FOSFOMYCINFosfomycin | Card DatabaseReference Gene Catalog | Confirmed |
| W425R | - | hexose phosphate transporter UhpT, single resistance variant | Staphylococcus aureus | FOSFOMYCINFosfomycin | Card DatabaseReference Gene Catalog | Confirmed |
| Y314Ter | - | hexose phosphate transporter UhpT, nonsense mutation | Staphylococcus aureus | FOSFOMYCINFosfomycin | Card DatabaseReference Gene Catalog | Confirmed |
| G141del | - | Escherichia coli | Fosfomycin | Reslit | Candidate |
| Allele | Database | Papers | Drug Classes | Organisms | Countries | Years | Sequence Accession | Protein Accession |
|---|---|---|---|---|---|---|---|---|
| uhpT | Reslit | 11 | Fosfomycin, Ampicillin +14 | Escherichia coli +4 | Spain, Shanghai, Sichuan, China, Europe, Bangladesh | 2015, 2018, 2020, 2022, 2023, 2025 | SRX2676277|SRX2676278|SRX2676279|SRX2676280|SRX2676281|SRX2676282|SRX2676285|SRX2676286|SRX2676287|SRX2676288 | - |
| uhpT_E350Q | Reslit | 1 | Fosfomycin | Escherichia coli | Kuwait | 2022 | SRX8356292|SRX8356293|SRX8356294|SRX8356295|SRX8344629|SRX8344630|SRX8344631|SRX8344632 | - |
Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions.
The study shows that elevated expression of glpT and uhpT in anaerobic conditions increases fosfomycin susceptibility in E. coli by enhancing drug uptake.
Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.
The study identifies that fosfomycin-nonsusceptible inner colony mutants in E. coli arise due to the loss of function or induction of UhpT, primarily through deletions in uhpT or nonsense mutations in uhpA.
Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in Escherichia coli Isolated in Clinical Urine Samples.
The study identifies fosA3 as a novel plasmid-mediated fosfomycin resistance gene in E. coli isolates in Spain. Fosfomycin resistance is primarily due to defects in the UhpT transporter system, while nitrofurantoin resistance involves mutations in nfsA, nfsB, and ribE genes.
Whole Genome Sequence Analysis of Multidrug Resistant Escherichia coli and Klebsiella pneumoniae Strains in Kuwait.
The study identified multiple AMR genes in multidrug-resistant E. coli and K. pneumoniae isolates from Kuwait, including beta-lactamases (blaKPC-2, blaCTX-M-15, blaOXA-1, blaCMY-4, blaTEM), aminoglycoside-modifying enzymes (aac(3)-IIa, aph(6)-Id, aadA5), sulfonamide resistance genes (sul1, sul2), quinolone resistance genes (gyrA_D87N, qnrB1), and others. Colistin resistance was linked to the pmrB_R256G mutation.
Mechanisms of high-level fosfomycin resistance in Staphylococcus aureus epidemic lineage ST5.
High-level fosfomycin resistance in S. aureus ST5 lineage is mainly due to mutations in glpT and uhpT, whereas ST239 resistance is mainly due to mutations in hptA.
Phenotypic and genotypic characterization of antimicrobial resistance profiles in Salmonella isolated from waterfowl in 2002-2005 and 2018-2020 in Sichuan, China.
The study identified multiple AMR genes and mutations in Salmonella isolates from waterfowl in Sichuan, China, including beta-lactamases, aminoglycoside-modifying enzymes, tetracycline efflux pumps, and quinolone resistance genes. Mutations in gyrA and gyrB were associated with nalidixic acid resistance.
Pervasive Selection for Clinically Relevant Resistance and Media Adaptive Mutations at Very Low Antibiotic Concentrations.
The study identifies clinically relevant resistance mutations in E. coli under subMIC antibiotic concentrations, showing that mutations in glpT, uhpT, uhpC, uhpA, nfsA, nfsB, gyrA, gyrB, and envZ confer resistance to fosfomycin, nitrofurantoin, ciprofloxacin, and tetracycline.
Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective Treatment.
This review discusses the molecular basis of challenges to effective treatment of UPEC-associated urinary tract infections, focusing on virulence factors and antibiotic resistance mechanisms.
Detection of Possible Resistance Mechanisms in Uropathogenic Escherichia coli Strains Isolated from Kidney Transplant Recipients Based on Whole Genome Sequencing.
The study identifies mutations in the gyrA gene and the presence of the qnrS1 gene as key contributors to quinolone resistance in uropathogenic E. coli strains. Additionally, mutations in glpT, cyaA, and uhpT genes are associated with fosfomycin resistance.
Synergistic antibacterial activity and prevention of drug resistance of daptomycin combined with fosfomycin against methicillin-resistant Staphylococcus aureus.
The study found that daptomycin and fosfomycin combination displayed synergistic antibacterial activity against MRSA and prevented the emergence of drug-resistant mutants. Specific mutations in mprF, cls2, uhpT, and murA genes were identified in single-drug resistant mutants, but no mutations were detected in the combination group.
Genomic Characterization of Pan-Drug Resistant Klebsiella pneumoniae KPNW Isolated From UTI Patient in Bangladesh.
The study identifies 42 antimicrobial resistance (AMR) genes in the pan-drug resistant Klebsiella pneumoniae isolate KPNW, including beta-lactamases (bla CTX-M-15, bla NDM-1, bla OXA-1, bla TEM-63, bla TEM-104, bla SHV-28), tetracycline resistance genes (tet(A)), and efflux pump genes (oqxA, oqxB, marA, marR, ompK37, pbp3, crp, h-ns, kpnG, kpnH, parC, rsmA). Additionally, the isolate shows resistance to polymyxin B and colistin through modifications in lipid A (eptB, arnT, lptD, msbA, vanG) and other mechanisms.
Multidrug-resistant Pseudomonas aeruginosa: Pathogenesis, resistance mechanisms, and novel therapeutic strategies.
The paper discusses the multidrug resistance mechanisms of Pseudomonas aeruginosa, including beta-lactamases, aminoglycoside modifying enzymes, efflux pumps, and mutations in porin genes. It highlights the role of these mechanisms in antibiotic resistance and the challenges they pose in treating infections.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research